[Journal of Clinical Investigation] To investigate the immunomodulatory effects of poly(ADP-ribose) polymerase inhibitors in an unbiased manner, researchers performed bulk RNA sequencing on homologous recombination repair-proficient MycCaP cells treated with the PARP inhibitor olaparib versus vehicle control.